TWINKLE PATEL: Open Payments
NPI 1205445293 · NORTH CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,106 in 94 payments from 31 companies in 2025. Trend: 2023 $3,037 · 2024 $3,089 · 2025 $3,106
Food & beverage: $2,906Education: $200
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 14 | $495 |
| Daiichi Sankyo Inc. | 4 | $279 |
| Syndax Pharmaceuticals, Inc. | 4 | $277 |
| Incyte Corporation | 10 | $240 |
| Novartis Pharmaceuticals Corporation | 7 | $195 |
| Merck Sharp & Dohme LLC | 7 | $176 |
| GENZYME CORPORATION | 3 | $124 |
| Exelixis Inc. | 1 | $121 |
| Janssen Biotech, Inc. | 4 | $120 |
| Lilly USA, LLC | 4 | $106 |
Products named: REVUFORJ, DATROWAY, IMFINZI, KEYTRUDA, ENHERTU, LYNPARZA, JAKAFI, WAYRILZ.
Industry payments across IL — which companies pay providers there.
